semaglutide type 1 diabetes randomized trial 2024 Subcutaneously administered tirzepatide vs for adults with 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Efficacy and safety of oral

Understanding the relationship between semaglutide and UTI symptoms helps patients distinguish medication side effects from unrelated infections and maintain appropriate vigilance for urinary symptoms requiring medical attention

If you do experience side effects, they usually subside after a few weeks of your body getting used to the medication

10.1007/s10555-024-10192-9 32 IwamotoY.KimuraT.DanK.IwamotoH.SanadaJ.FushimiY.et al (2024)

However, the FDA labels for all semaglutide products note that serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported in patients treated with semaglutide

Finally, a May 2025 head-to-head trial published in NEJM compared tirzepatide with semaglutide directly